1. Home
  2. CPRT vs INCY Comparison

CPRT vs INCY Comparison

Compare CPRT & INCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Copart Inc. (DE)

CPRT

Copart Inc. (DE)

N/A

Current Price

$31.24

Market Cap

29.6B

ML Signal

N/A

Logo Incyte Corp.

INCY

Incyte Corp.

N/A

Current Price

$114.90

Market Cap

24.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CPRT
INCY
Founded
1982
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Commercial Physical & Biological Resarch
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.6B
24.5B
IPO Year
1996
1994

Fundamental Metrics

Financial Performance
Metric
CPRT
INCY
Price
$31.24
$114.90
Analyst Decision
Buy
Buy
Analyst Count
12
28
Target Price
$39.00
★ $132.17
AVG Volume (30 Days)
★ 9.7M
1.5M
Earning Date
12-01-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 4173.33
EPS
★ 1.55
0.50
Revenue
$1,805,695,000.00
★ $3,394,635,000.00
Revenue This Year
$17.88
$17.74
Revenue Next Year
$12.05
$4.38
P/E Ratio
★ $19.91
$231.80
Revenue Growth
N/A
★ 13.67
52 Week Low
$25.72
$89.25
52 Week High
$41.79
$132.60

Technical Indicators

Market Signals
Indicator
CPRT
INCY
Relative Strength Index (RSI) 54.54 41.81
Support Level $29.97 $109.78
Resistance Level $34.12 $119.29
Average True Range (ATR) 0.87 3.73
MACD -0.15 -0.53
Stochastic Oscillator 19.04 3.94

Price Performance

Historical Comparison
CPRT
INCY

About CPRT Copart Inc. (DE)

Based in Dallas, Copart operates a global online salvage-vehicle auction with operations in 11 countries across North America, Europe, and the Middle East, facilitating over 4 million transactions annually. The company utilizes its virtual bidding platform, VB3, to connect vehicle sellers with over 1 million registered buyers around the world. Buyers primarily consist of vehicle dismantlers, rebuilders, individuals, and used-vehicle retailers. About 80% of Copart's vehicle volume is supplied by auto insurance companies holding vehicles deemed a total loss. Copart also offers services such as vehicle transportation, storage, title transfer, and salvage value estimation. The company primarily operates on a consignment basis and collects fees based on the vehicle's final selling price.

About INCY Incyte Corp.

Incyte focuses on the discovery and development of small-molecule drugs. The firm's leading drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis and 2022 for vitiligo. Incyte's pipeline includes an array of oncology and dermatology programs.

Share on Social Networks: